Judgment of the Court (Sixth Chamber) of 3 March 2016. Teva Pharma BV and Teva Pharmaceuticals Europe BV v European Medicines Agency (EMA). Appeal — Orphan medicinal products — Regulation (EC) No 141/2000 — Regulation (EC) No 847/2000 — Refusal to grant marketing authorisation for the generic version of the orphan medicinal product ‘imatinib mesylate’.